PANORAMA AND TRENDS OF THE GLOBAL PHARMACEUTICAL MARKET

With the development of the global economy, the growth of the total population and the aging of society, the demand for drugs is increasing, and the market size of the global pharmaceutical industry will maintain growth. stable.
In 2023, the total global pharmaceutical market is estimated to be approximately US$1,6 trillion. This is an increase of more than $100 billion compared to 2022. According to Frost & Sullivan analysis, the global pharmaceutical market size is expected to reach $1.681,4 billion by 2025, with a compound annual growth rate. year is 5,3%.
In the future, due to the aging of the population, drug innovation and the growth of total medical and health costs, the global pharmaceutical market is expected to reach 2.033,3 billion USD by 2030, at a rapid rate of Compound annual growth rate is 3,9% from 2025. So what are the trends of the global pharmaceutical market?

1. Biopharmaceuticals will maintain an explosive growth trend in the medium and long term
   In 2020, an unexpected health crisis swept the world. Although the COVID-19 epidemic has now subsided a lot, its effects still linger… The development of the biomedical industry is one of the things that cannot be ignored.
   
   The global pharmaceutical market includes chemical drugs and biological drugs. From the perspective of revenue structure, chemical drugs are the main component of the global pharmaceutical market, but currently, the global biopharmaceutical market is experiencing a boom.
   With the rapid development of biotechnology (Bio-Tech), the diversity and therapeutic scope of biological drugs are constantly being optimized, while highlighting advantages and characteristics such as safety, effective and widely applicable. The scale and market share are expanding, and antibody drugs have become the best-selling and fastest-growing drugs in the world.
   The global biopharmaceutical industry tends to develop in clusters, mainly concentrated in the US, Europe, Japan, India, Singapore, China and Southeast Asian countries. main driving force.
   It can be said that the biopharmaceutical industry is not only the most important application direction of biotechnology but also the key to the transformation and upgrading of the modern pharmaceutical industry.
2. The number of generic drugs is increasing rapidly
   In recent years, the rapid development of the global pharmaceutical market is mainly due to 2 aspects: On the one hand, the patents of some key drugs will gradually expire, on the other hand allowing many drugs More generics are entering the market.
   As the global population ages and new drugs become more expensive, medical costs become increasingly burdensome… many Governments have begun to actively encourage the use of generic drugs. Generic drugs will remain a major contributor to the growth of the pharmaceutical market in the coming years.
   After the patent of the original drug expires, the relative monopoly position of the original research enterprises no longer exists. The characteristic of the generic drug market is that it is gradually moving closer to price competition. At this time, cost control becomes the key for businesses to focus on core issues, but pharmaceutical production still has a very high threshold for supply capacity and stable supply of pharmaceutical substances (APIs). ), technical reserves, environmental protection capabilities and cost advantages. Because of benefiting from the growth of the generic drug market, demand for API companies is also expected to increase rapidly.
   
3. Cancer treatment drugs are expected to have the largest growth in the coming years
   The pharmaceutical industry is driven by a number of factors, including advances in technology, demographic changes and regulatory policies. The major factor expected to drive the growth of the pharmaceutical market is the increase in life expectancy. The concomitant rise in chronic and infectious diseases has led to a growing market for specialty drugs, targeting specific patient groups.
   Oncology is a treatment area open to global drug sales and is expected to experience the greatest growth in the coming years. Next is spending on drugs for autoimmune diseases and diabetes.
4. AI research and drug development
   One of the main drivers of the pharmaceutical market is research and development. Pharmaceutical companies invest heavily in R&D to develop new drugs and treatments that can improve medical outcomes and address unmet medical needs.
   For example, artificial intelligence (AI) in drug development offers exciting possibilities for the pharmaceutical industry. By shortening the time in drug development, the industry can save tens of millions of dollars each year, bring treatments to market faster and ultimately improve clinical outcomes. of the patient.
   One of the pharmaceutical industry’s most striking statistics is that spending on AI will reach $3 billion by 2025 as companies invest in technology that can reduce the time and cost needed to bring new drugs to market. school. Therefore, AI-based drug development alliances are also constantly increasing.

Source: SUC KHOE & DOI SONG

About STELLAPHARM

Stellapharm is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, antiviral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.

The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.

Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An City, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: info@stellapharm.com | W: www.stellapharm.com